The American Medical Association, American Pharmacists Association, American Society of Health-System Pharmacists and National Community Pharmacists Association cited several examples in which ambiguity around the legal risks of prescribing or dispensing drugs that could be used to induce abortion has disrupted patient care.
“At some health systems and hospitals, we have heard reports of legal counsel, tasked with minimizing legal exposure for their institution and employees, prioritizing caution over access and advising against providing certain medications,” the groups said.
To help physicians and pharmacists navigate a confusing legal landscape in the wake of Roe v. Wade’s overturning, state boards, health agencies and other policymakers must issue clear guidance on the prescribing and dispensing of drugs that could be used to induce abortion, the groups said.
“Without such guidance, we are deeply concerned that our patients will lose access to care and suffer irreparable harm,” they said.
Read the full statement here.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.